semaglutide news today 2025 In the OASIS 4 phase 3 trial, once-daily oral at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or Type 2 Diabetes in 2025:

It may also improve blood pressure and quality of life

SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week Are GLP-1 Patches Next

Q2: What is 'cag peptide' or 'reta/cag'

It is a GLP-1 agonist so it encourages the pancreas to release insulin appropriately while slowing down stomach emptying, resulting in slowed digestion, reduced appetite, and better stabilized blood sugar and energy levels

Side Effects: The most common side effects reported in trials are primarily gastrointestinal, including nausea, vomiting, diarrhea, and constipation

Helt utan frg, stning och arom